• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同α-突触核蛋白菌株导致疾病异质性的证据。

Evidence of distinct α-synuclein strains underlying disease heterogeneity.

机构信息

Department of Biology, Institute for Applied Life Sciences, University of Massachusetts Amherst, Amherst, MA, USA.

出版信息

Acta Neuropathol. 2021 Jul;142(1):73-86. doi: 10.1007/s00401-020-02163-5. Epub 2020 May 21.

DOI:10.1007/s00401-020-02163-5
PMID:32440702
Abstract

Synucleinopathies are a group of neurodegenerative disorders caused by the misfolding and self-templating of the protein α-synuclein, or the formation of α-synuclein prions. Each disorder differs by age of onset, presenting clinical symptoms, α-synuclein inclusion morphology, and neuropathological distribution. Explaining this disease-specific variability, the strain hypothesis postulates that each prion disease is encoded by a distinct conformation of the misfolded protein, and therefore, each synucleinopathy is caused by a unique α-synuclein structure. This review discusses the current data supporting the role of α-synuclein strains in disease heterogeneity. Several in vitro and in vivo models exist for evaluating strain behavior, however, as the focus of this article is to compare strains across synucleinopathy patients, our discussion predominantly focuses on the two models most commonly used for this purpose: the α-syn140*A53T-YFP cell line and the TgM83 mouse model. Here we define each strain based on biochemical stability, ability to propagate in α-syn140-YFP cell lines, and incubation period, inclusion morphology and distribution, and neurological signs in TgM83 mice.

摘要

突触核蛋白病是一组由蛋白质α-突触核蛋白错误折叠和自模板化或α-突触核蛋白朊病毒形成引起的神经退行性疾病。每种疾病的发病年龄、临床表现、α-突触核蛋白包涵体形态和神经病理学分布均不同。为了解释这种疾病特异性的变异性,菌株假说假设每种朊病毒疾病都由错误折叠蛋白的独特构象编码,因此,每种突触核蛋白病都是由独特的α-突触核蛋白结构引起的。这篇综述讨论了支持α-突触核蛋白菌株在疾病异质性中的作用的现有数据。有几种体外和体内模型可用于评估菌株行为,但是,由于本文的重点是比较突触核蛋白病患者中的菌株,因此我们的讨论主要集中在为此目的最常用的两种模型:α-syn140*A53T-YFP 细胞系和TgM83 小鼠模型。在这里,我们根据生化稳定性、在α-syn140-YFP 细胞系中繁殖的能力以及潜伏期、包涵体形态和分布以及 TgM83 小鼠的神经学迹象来定义每种菌株。

相似文献

1
Evidence of distinct α-synuclein strains underlying disease heterogeneity.不同α-突触核蛋白菌株导致疾病异质性的证据。
Acta Neuropathol. 2021 Jul;142(1):73-86. doi: 10.1007/s00401-020-02163-5. Epub 2020 May 21.
2
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism.α-突触核蛋白朊病毒导致帕金森综合征患者发生多系统萎缩的证据。
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):E5308-17. doi: 10.1073/pnas.1514475112. Epub 2015 Aug 31.
3
Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines.多系统萎缩朊病毒在两种不同的 Tg(SNCA*A53T)小鼠品系中连续传播后仍保持株型特异性。
Acta Neuropathol. 2019 Mar;137(3):437-454. doi: 10.1007/s00401-019-01959-4. Epub 2019 Jan 28.
4
Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice.人源α-突触核蛋白转基因小鼠中的神经核蛋白病具有独特的播散特征和朊病毒样传播特性,且高度依赖宿主。
Acta Neuropathol. 2022 Jun;143(6):663-685. doi: 10.1007/s00401-022-02425-4. Epub 2022 Apr 30.
5
Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.多系统萎缩相关少突胶质细胞蛋白 p25α 刺激具有增强神经退行性潜能的新型 α-突触核蛋白菌株的形成。
Acta Neuropathol. 2021 Jul;142(1):87-115. doi: 10.1007/s00401-021-02316-0. Epub 2021 May 12.
6
Familial Parkinson's point mutation abolishes multiple system atrophy prion replication.家族性帕金森病点突变消除了多系统萎缩朊病毒复制。
Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):409-414. doi: 10.1073/pnas.1719369115. Epub 2017 Dec 26.
7
Transmission of prion strains in a transgenic mouse model overexpressing human A53T mutated α-synuclein.在过表达人 A53T 突变α-突触核蛋白的转基因小鼠模型中朊病毒株的传播。
J Neuropathol Exp Neurol. 2011 May;70(5):377-85. doi: 10.1097/NEN.0b013e318217d95f.
8
Kinetics of α-synuclein prions preceding neuropathological inclusions in multiple system atrophy.α-突触核蛋白朊病毒在多系统萎缩神经病理学包涵体之前的动力学。
PLoS Pathog. 2020 Feb 4;16(2):e1008222. doi: 10.1371/journal.ppat.1008222. eCollection 2020 Feb.
9
Prominent microglial inclusions in transgenic mouse models of α-synucleinopathy that are distinct from neuronal lesions.在 α-突触核蛋白病的转基因小鼠模型中,突出的小胶质细胞包含物有别于神经元病变。
Acta Neuropathol Commun. 2020 Aug 12;8(1):133. doi: 10.1186/s40478-020-00993-8.
10
ɑ-Synuclein strains and the variable pathologies of synucleinopathies.α-突触核蛋白毒株与突触核蛋白病的多样病理学表现
J Neurochem. 2016 Oct;139 Suppl 1:256-274. doi: 10.1111/jnc.13595. Epub 2016 Mar 30.

引用本文的文献

1
Novel in situ seeding immunodetection assay uncovers neuronal-driven alpha-synuclein seeding in Parkinson's disease.新型原位接种免疫检测法揭示帕金森病中神经元驱动的α-突触核蛋白种子形成。
NPJ Parkinsons Dis. 2025 Aug 25;11(1):259. doi: 10.1038/s41531-025-01111-y.
2
The role of T cells in the treatment of Parkinson's disease.T细胞在帕金森病治疗中的作用。
PeerJ. 2025 Aug 14;13:e19818. doi: 10.7717/peerj.19818. eCollection 2025.
3
Evidence of a novel α-synuclein strain isolated from a Parkinson's disease with dementia patient sample.

本文引用的文献

1
Kinetics of α-synuclein prions preceding neuropathological inclusions in multiple system atrophy.α-突触核蛋白朊病毒在多系统萎缩神经病理学包涵体之前的动力学。
PLoS Pathog. 2020 Feb 4;16(2):e1008222. doi: 10.1371/journal.ppat.1008222. eCollection 2020 Feb.
2
The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure.α-突触核蛋白遗传突变 E46K 解锁了一种更稳定、致病性的纤维结构。
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3592-3602. doi: 10.1073/pnas.1917914117. Epub 2020 Feb 3.
3
Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy.
从一名帕金森病合并痴呆患者样本中分离出新型α-突触核蛋白毒株的证据。
Acta Neuropathol Commun. 2025 Aug 18;13(1):177. doi: 10.1186/s40478-025-02093-x.
4
Age-dependent progression from clearance to vulnerability in the early response of periventricular microglia to α-synuclein toxic species.室周小胶质细胞对α-突触核蛋白毒性物质早期反应中,从清除到易损性的年龄依赖性进展。
Mol Neurodegener. 2025 Mar 5;20(1):26. doi: 10.1186/s13024-025-00816-1.
5
Structurally targeted mutagenesis identifies key residues supporting α-synuclein misfolding in multiple system atrophy.结构靶向诱变确定了支持多系统萎缩中α-突触核蛋白错误折叠的关键残基。
J Parkinsons Dis. 2024 Nov;14(8):1543-1558. doi: 10.3233/JPD-240296. Epub 2024 Oct 17.
6
Transcriptional dysregulation in the cerebellum triggered by oligodendroglial α-synucleinopathy: insights from a transgenic mouse into the early disease mechanisms of MSA.少突胶质细胞α-突触核蛋白病引发的小脑转录失调:来自转基因小鼠对多系统萎缩早期疾病机制的见解。
J Neural Transm (Vienna). 2025 Feb 15. doi: 10.1007/s00702-025-02892-5.
7
Tracing TMEM106B fibril deposition in aging and Parkinson's disease with dementia brains.追踪衰老和帕金森病伴痴呆症大脑中TMEM106B原纤维沉积情况。
Life Med. 2024 Mar 7;3(1):lnae011. doi: 10.1093/lifemedi/lnae011. eCollection 2024 Feb.
8
α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation.α-突触核蛋白种子扩增检测在突触核蛋白病诊断中的应用:临床实施中的创新工具。
Transl Neurodegener. 2024 Nov 21;13(1):56. doi: 10.1186/s40035-024-00449-2.
9
Single-Molecule Fingerprinting Reveals Different Growth Mechanisms in Seed Amplification Assays for Different Polymorphs of α-Synuclein Fibrils.单分子指纹图谱揭示了不同 α-突触核蛋白纤维多形体在种子扩增试验中的不同生长机制。
ACS Chem Neurosci. 2024 Sep 18;15(18):3270-3285. doi: 10.1021/acschemneuro.4c00185. Epub 2024 Aug 28.
10
Current insights and assumptions on α-synuclein in Lewy body disease.目前对路易体病中α-突触核蛋白的认识和假设。
Acta Neuropathol. 2024 Aug 14;148(1):18. doi: 10.1007/s00401-024-02781-3.
两种新的人类全长α-突触核蛋白纤维的多晶型结构通过冷冻电镜解析。
Elife. 2019 Dec 9;8:e48907. doi: 10.7554/eLife.48907.
4
Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts.从患者脑组织提取物中放大的α-突触核蛋白纤维的结构异质性。
Nat Commun. 2019 Dec 4;10(1):5535. doi: 10.1038/s41467-019-13564-w.
5
α-Synuclein strains target distinct brain regions and cell types.α-突触核蛋白纤维靶向不同的大脑区域和细胞类型。
Nat Neurosci. 2020 Jan;23(1):21-31. doi: 10.1038/s41593-019-0541-x. Epub 2019 Dec 2.
6
Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs.由α-突触核蛋白遗传疾病突变体 H50Q 形成的原纤维结构揭示了新的多态性。
Nat Struct Mol Biol. 2019 Nov;26(11):1044-1052. doi: 10.1038/s41594-019-0322-y. Epub 2019 Nov 6.
7
Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes.猴脑内的α-突触核蛋白纤维:扩散、成像和神经病理学改变。
Brain. 2019 Nov 1;142(11):3565-3579. doi: 10.1093/brain/awz296.
8
Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils.用 MSA 脑裂解物和重组α-突触核蛋白纤维在转基因小鼠体内诱导和传播α-突触核蛋白病的比较分析。
Acta Neuropathol Commun. 2019 May 20;7(1):80. doi: 10.1186/s40478-019-0733-3.
9
Full restoration of specific infectivity and strain properties from pure mammalian prion protein.从纯哺乳动物朊蛋白中完全恢复特定感染性和株特性。
PLoS Pathog. 2019 Mar 25;15(3):e1007662. doi: 10.1371/journal.ppat.1007662. eCollection 2019 Mar.
10
Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics.帕金森病和多系统萎缩具有不同的α-突触核蛋白种子特征。
J Biol Chem. 2019 Jan 18;294(3):1045-1058. doi: 10.1074/jbc.RA118.004471. Epub 2018 Nov 26.